Citric Acid

Citric Acid

SCHEMBL2515258

CC(O)C(=O)O.CC(O)C(=O)O.Cl.Cl.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)O.O=C(O)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=P(O)(O)O.O=P(O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[O-2].[O-2]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.42
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL2518499 0.88 PDE4A (0.51) PDE4AALDH1A1LMNA
Gluconic Acid SCHEMBL28829555 0.86 PDE4A (0.54) PDE4AALDH1A1LMNA
Gluconic Acid SCHEMBL27650807 0.86 PDE4A (0.58) PDE4AALDH1A1LMNA
Gluconic Acid SCHEMBL20876306 0.86 PDE4A (0.58) PDE4AALDH1A1LMNA
Citric Acid SCHEMBL301655 0.86 PDE4A (0.58) PDE4AALDH1A1LMNA
Gluconic Acid SCHEMBL27097002 0.84 PDE4A (0.56) PDE4AALDH1A1LMNA
Citric Acid SCHEMBL301849 0.84 PDE4A (0.56) PDE4AALDH1A1LMNA
Citric Acid SCHEMBL17513691 0.80 PDE4A (0.58) PDE4AALDH1A1LMNA
Citric Acid SCHEMBL10802994 0.80 PDE4A (0.61) PDE4AALDH1A1LMNA
Gluconic Acid SCHEMBL28106011 0.80 PDE4A (0.66) PDE4AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110250270-A1 Compositions containing a capillary-active system with application-relevant diffferentiability and their use MERZ PHARMA GMBH & CO. KGAA (DE) 2011-10-13 US disclosed
US-20080317856-A1 Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof MERZ PHARMA GMBH & CO. KGAA (DE) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080317856-A1 Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof LIPG, FABP2, CPT1B PDE4A 634/4885ALDH1A1 1691/4885LMNA 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.